The world of U.S. biomedical research faces formidable challenges as budget cuts pose a graver risk to scientific progress than ever before. A startling revelation in the form of financial reductions has left many researchers questioning the future of some of the nation’s most critical medical a
Faisal Zain is a healthcare expert specializing in medical technology. He has extensive experience in the manufacturing of medical devices used for diagnostics and treatment, driving innovation in the field. David Wainson engages him in a discussion about the recent closure of the CDC's STD
Surrey, British Columbia, has experienced significant transformation over the past few years. Emerging as a crucial center for biotechnology and health technology, the city has strategically positioned itself as a burgeoning hub for health and life sciences. The concerted efforts of government and
DHL Group, the world's leading logistics provider, made a strategic move by acquiring CRYOPDP, a specialty courier focused on clinical trials, biopharma, and cell and gene therapies. This acquisition aims to bolster DHL's "Health Logistics" division by leveraging CRYOPDP's
Researchers have recently uncovered a fascinating aspect of bacterial life: the discovery of a protein-degrading enzyme in Escherichia coli (E. coli) bacteria that becomes active postmortem. This enzyme, known as Lon protease, plays a crucial role after the bacterial cells die, triggering a vital
California State University, Fullerton (CSUF) recently organized the Health Pathways Fair, a dynamic event that drew over 500 high school, community college, and CSUF students. This event served to provide valuable insights and hands-on experiences about various healthcare careers, playing a
